Clinical trial
Depression Treatment and Aβ Dynamics: A Study of Alzheimer's Disease Risk (ABD Study)
NCT05004987 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Depression Treatment and Aβ Dynamics: A Study of Alzheimer's Disease Risk (ABD Study)
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- February 4, 2022
- Completion date
- June 30, 2027
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.